Article info

Download PDFPDF

Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study

Authors

  1. Correspondence to Dr SeungJin Bae; sjbae{at}ewha.ac.kr
View Full Text

Citation

Cho H, Choi KS, Lee JY, et al
Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study

Publication history

  • Received April 9, 2019
  • Revised August 12, 2019
  • Accepted September 3, 2019
  • First published September 20, 2019.
Online issue publication 
September 20, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.